What is the CVR number of Freya Biosciences License ApS?

Freya Biosciences License ApS is registered with CVR / Virk under CVR 41372079.

What is the revenue of Freya Biosciences License ApS?

Freya Biosciences License ApS reported revenue of -14,0 t kr. in 2025.

Peter Finsel Bisgaard chairs the board of Freya Biosciences License ApS, in role since 2022.

Freya Biosciences License ApS's registered address is Fruebjergvej 3.

APSActiveAdvertising protection

CVR 41372079Fruebjergvej 3, 2100 København ØManufacture of pharmaceutical preparations· NACE 2120Est. 2020 · 6 years old— employees

Actively employed in the business

Name	Role	Member since
Current (4)
LM Laura Marie Ensign-Hodges Founder	Founder	2020
MC MBFH Consulting SAS Founder	Founder	2020
UK Ulrich Klaus Binné Founder	Founder	2020
PF Peter Finsel Bisgaard Founder	Founder	2020

Former (2)


CD Colleen Denise Acosta Chief Executive Officer	Chief Executive Officer	2020 – 2022
LS Lars Skanvig Bramhelft Unofficial title	Unofficial title	2022 – 2022

Non-executive oversight

Name	Role	Member since
Current (7)
CD Colleen Denise Acosta Board of Directors	Board of Directors	2022
MS Mark Smith Board of Directors	Board of Directors	2022
CM Claudia Maria Colciago Board of Directors	Board of Directors	2023
NH Nicholas Haft Board of Directors	Board of Directors	2022
DL David Lawrence Stern Board of Directors	Board of Directors	2024
HE Henrijette Elsebeth Richter Board of Directors	Board of Directors	2022
PF Peter Finsel Bisgaard Chairman	Chairman	2022

Former (2)


TG Thomas Gundelund Rasmussen Board of Directors	Board of Directors	2020 – 2020
JE Johannes Epeüs Theodoor van Hylckama Vlieg Board of Directors	Board of Directors	2020 – 2020

As of last annual report

Shareholder	Type	Ownership	Votes	Since
Sofinnova Capital X	Individual	20–24.99%	20–24.99%	2023
Bill & Melinda Gates Foundation	Individual	15–19.99%	15–19.99%	2025
Danmarks Eksport- og Investeringsfond	Company	10–14.99%	10–14.99%	2024
OMX Opportunity Fund I, LLC	Company	5–9.99%	5–9.99%	2023
Sofinnova Capital IX	Individual	5–9.99%	5–9.99%	2024
OMX Ventures Fund I, LLC	Company	5–9.99%	5–9.99%	2024
VÆKSTFONDEN	Company	10–14.99%	10–14.99%	2023
ABT Consult ApS	Company	5–9.99%	5–9.99%	2020
R. Rich Holding ApS	Company	5–9.99%	5–9.99%	2020
Curanthia Holdings ApS	Company	5–9.99%	5–9.99%	2023
Origem Holding ApS	Company	5–9.99%	5–9.99%	2023
MBFH Consulting SAS	Individual	5–9.99%	5–9.99%	2023
Peter Finsel Bisgaard	Individual	5–9.99%	5–9.99%	2023

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.